Higher expression levels of STMN1 and TUBA1B are associated with shorter progression-free and overall survival in the CoMMpass dataset of the Multiple Myeloma Research Foundation (https://research.themmrf.org/, Supplemental Fig. 2). This evidence concerns the gene TUBA1B and plasma cell myeloma.